Shao, Feng
Jiang, Yi
Ding, Sijia
Larsson, Per
Pinton, Philippe http://orcid.org/0000-0002-4227-7687
Jonker, Daniƫl Martijn http://orcid.org/0000-0002-8227-9361
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
https://doi.org/10.1007/s40261-022-01232-9
Funding for this research was provided by:
Ferring Pharmaceuticals.
Article History
Accepted: 17 November 2022
First Online: 7 December 2022
Declarations
:
: The study was funded by Ferring Pharmaceuticals.
: DMJ, PL, and PP are employees of Ferring Pharmaceuticals. FS, YJ and SD have nothing to disclose.
: Data are available from the author (DMJ) upon reasonable request.
: The study was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University and conducted in accordance with the Declaration of Helsinki and International Council for Harmonisation (ICH) guidelines for Good Clinical Practice (GCP).
: All subjects gave their written informed consent before enrolment in the study.
: SF, YJ, and SD collected the study data; PL performed the statistical analysis and contributed to the data interpretation; PP contributed to the data interpretation and to the manuscript writing; DMJ performed the pharmacokinetic analysis and contributed to the data interpretation and to the manuscript writing. All authors approved the submitted version of the manuscript.
: Not applicable.
: Not applicable.